↓ Skip to main content

Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
33 X users
patent
3 patents
googleplus
2 Google+ users

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden
Published in
Journal for Immunotherapy of Cancer, September 2017
DOI 10.1186/s40425-017-0281-y
Pubmed ID
Authors

Victoria E. Wang, Anatoly Urisman, Lee Albacker, Siraj Ali, Vincent Miller, Rahul Aggarwal, David Jablons

X Demographics

X Demographics

The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 15%
Researcher 7 13%
Other 5 10%
Student > Postgraduate 5 10%
Student > Bachelor 4 8%
Other 8 15%
Unknown 15 29%
Readers by discipline Count As %
Medicine and Dentistry 16 31%
Biochemistry, Genetics and Molecular Biology 6 12%
Agricultural and Biological Sciences 2 4%
Nursing and Health Professions 2 4%
Computer Science 2 4%
Other 1 2%
Unknown 23 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#1,350,531
of 25,634,695 outputs
Outputs from Journal for Immunotherapy of Cancer
#329
of 3,471 outputs
Outputs of similar age
#26,435
of 326,032 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#6
of 20 outputs
Altmetric has tracked 25,634,695 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,471 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,032 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.